TRATAMENTO DE FIBROSE UTILIZANDO LIGANDOS DE RFX

• 收藏
• 分享

专利权人:

INTERCEPT PHARMACEUTICALS; INC.

发明人:

ROBERTO PELLICCIARI,STEFANO FIORUCCI,MARK PRUZANSKI

申请号：

PT05729394

公开号：

PT1734970E

申请日:

2005.03.14

申请国别(地区):

PT

年份:

2015

代理人:

摘要：

The present invention relates to a method for inhibiting fibrosis that occurs in an organ where the farnesoid X receptor (FXR) is expressed. This method involves the step of administering a high potency, activating ligand of FXR in an effective amount to a patient who is not suffering from a cholestatic condition. The invention also provides pharmaceutical compositions containing an effective amount of an FXR ligand and kits for dispensing the pharmaceutical compositions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/